DNA methyltransferase 3A induces the occurrence of oral submucous fibrosis by promoting the methylation of the von Hippel-Lindau
- PMID: 37743610
- DOI: 10.1111/odi.14725
DNA methyltransferase 3A induces the occurrence of oral submucous fibrosis by promoting the methylation of the von Hippel-Lindau
Abstract
Background: Oral submucous fibrosis (OSF) is associated with malignant disorders. DNA methyltransferase 3A (DNMT3A) is a DNA methylesterase reported to be upregulated in multiple organs and shown to inhibit fibrosis. However, the detailed effect of DNMT3A on OSF remains unclear.
Methods: To mimic OSF in vitro, oral fibroblasts were exposed to arecoline and molecular biological experiments were performed to detect the function of DNMT3A in OSF.
Results: We found that von Hippel-Lindau (VHL) was downregulated and highly methylated in OSF. Arecoline remarkably increased the viability, invasiveness, and migration of oral fibroblasts, but upregulation of VHL partially reversed these effects. DNMT3A induces DNA hypermethylation in the VHL promoter, and VHL markedly inhibits the level of tenascin-C (TNC) by inducing the ubiquitination of TNC. TNC reversed the inhibitory effect of VHL upregulation on the differentiation of oral fibroblasts into myofibroblasts.
Conclusion: DNMT3A induces OSF by promoting methylation of the VHL promoter. Hence, our study provides novel insights into the discovery of novel strategies that can be employed against OSF.
Keywords: DNA methyltransferase 3A; methylation; tenascin‐C; von Hippel–Lindau.
© 2023 Wiley Periodicals LLC.
Similar articles
-
VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway.Sci Rep. 2025 Mar 4;15(1):7563. doi: 10.1038/s41598-025-91207-5. Sci Rep. 2025. PMID: 40038412 Free PMC article.
-
[Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jan 30;41(1):100-106. doi: 10.12122/j.issn.1673-4254.2021.01.14. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 33509760 Free PMC article. Chinese.
-
miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.J Cell Mol Med. 2018 Sep;22(9):4130-4138. doi: 10.1111/jcmm.13690. Epub 2018 Jun 12. J Cell Mol Med. 2018. PMID: 29893466 Free PMC article.
-
Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.Oral Dis. 2024 May;30(4):2314-2324. doi: 10.1111/odi.14656. Epub 2023 Jun 29. Oral Dis. 2024. PMID: 37382472
-
VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.Retina. 2019 Dec;39(12):2243-2253. doi: 10.1097/IAE.0000000000002555. Retina. 2019. PMID: 31095066 Review.
Cited by
-
VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway.Sci Rep. 2025 Mar 4;15(1):7563. doi: 10.1038/s41598-025-91207-5. Sci Rep. 2025. PMID: 40038412 Free PMC article.
-
Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis.Int J Oral Sci. 2024 Jun 20;16(1):48. doi: 10.1038/s41368-024-00302-2. Int J Oral Sci. 2024. PMID: 38897993 Free PMC article.
-
Molecular Genomics of Oral Submucous Fibrosis: A Narrative Review.Genes (Basel). 2025 May 22;16(6):612. doi: 10.3390/genes16060612. Genes (Basel). 2025. PMID: 40565504 Free PMC article. Review.
References
REFERENCES
-
- Brunetti, L., Gundry, M. C., & Goodell, M. A. (2017). DNMT3A in leukemia. Cold Spring Harbor Perspectives in Medicine, 7(2), a030320.
-
- Carey, W. A., Taylor, G. D., Dean, W. B., & Bristow, J. D. (2010). Tenascin‐C deficiency attenuates TGF‐ss‐mediated fibrosis following murine lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology, 299(6), L785–L793.
-
- Chittiboina, P., & Lonser, R. R. (2015). von Hippel–Lindau disease. Handbook of Clinical Neurology, 132, 139–156.
-
- Dees, C., Potter, S., Zhang, Y., Bergmann, C., Zhou, X., Luber, M., Wohlfahrt, T., Karouzakis, E., Ramming, A., Gelse, K., Yoshimura, A., Jaenisch, R., Distler, O., Schett, G., & Distler, J. H. W. (2020). TGF‐beta‐induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis. The Journal of Clinical Investigation, 130(5), 2347–2363.
-
- Ganner, A., Gehrke, C., Klein, M., Thegtmeier, L., Matulenski, T., Wingendorf, L., Wang, L., Pilz, F., Greidl, L., Meid, L., Kotsis, F., Walz, G., Frew, I. J., & Neumann‐Haefelin, E. (2021). VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma. Scientific Reports, 11(1), 14827.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous